A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression

Clinical trial NCT00566202 · COMPLETED

Trial details

NCT number: NCT00566202
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2007-12-01
Primary completion: 2008-12-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.